The particular interest to investigate these t (6;11) fusion proteins came from the clinical observation that leukemia patients with breakpoints in the major BCR are mostly diagnosed with AML, while patients with breakpoints in the minor BCR are exclusively diagnosed with T-ALL. The gene discussed is BCR; the disease is leukemia.